Literature DB >> 22387253

Optimal length of anticoagulant therapy in cirrhotic patients with portal vein thrombosis.

Kryssia Isabel Rodríguez-Castro, Marco Senzolo, Maria Teresa Sartori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22387253     DOI： 10.1016/j.cgh.2012.02.021

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  3 in total

1.  The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma.

Authors:  Nadia K Umar; Maaz B Badshah; Kumar Sandrasegaran; Marwan Ghabril; Saurabh Agarwal; Mark Tann; Marco Lacerda; Paul Y Kwo
Journal:  Dig Dis Sci       Date:  2015-03-17       Impact factor: 3.199

2.  Evaluation of portal vein thrombosis in liver graft ten years after liver transplantation due to budd-Chiari syndrome using Doppler ultrasound.

Authors:  Azra Husic-Selimovic; Srdjan Gornjakovic; Marcus Schuchmann; Zora Vukobrat-Bijedic
Journal:  Acta Inform Med       Date:  2012-09

Review 3.  Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View.

Authors:  Martin Rössle; Birke Bausch; Christoph Klinger
Journal:  Viszeralmedizin       Date:  2014-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.